Javascript must be enabled to continue!
Comparison of Efficacy of Azithromycin Versus Ceftriaxone in Treatment of Enteric Fever
View through CrossRef
Objective: Research was conducted at the Hayatabad Medical Complex in Peshawar to evaluate the relative effectiveness of azithromycin and ceftriaxone in the treatment of enteric fever. Methods: After the ethical approval from institute review board, this random controlled trial was conducted at Department of Pediatrics, Hayatabad Medical Complex, Peshawar, from 20 July, 2019 to 20 Jan, 2020. Each patient was randomly assigned to a treatment group through toss method in Group A and Group B. Patients in Group A received azithromycin (20 mg/kg/day; maximum, 1000 mg/day) and patients in Group B were administered with ceftriaxone (75 mg/kg/day; maximum, 2.5 g/day). Efficacy of both drugs was determined keeping in view complete resolution of symptoms of enteric fever within a week time. Results: The mean ± S. D of age of the participants in both groups were 5.38±1.95 and 5.74±1.84 years. The mean ± S. D of disease duration of the participants in both groups were 6.14±1.25 and 5.90±1.17 days. The mean ± S. D of time of defersevence of the participants in both groups were 2.38±0.57 and 4.66±0.716. In azithromycin group, 44 (88%) patients showed effective results while in the ceftriaxone group, 23 (46%) patients showed effective results. P Value = 0.000 Conclusion: Azithromycin could be a convenient and cheap alternative for the treatment of typhoid fever, especially in children in our local population. Keywords: Azithromycin, Ceftriaxone, Typhoid Fever
Lahore Medical and Dental College
Title: Comparison of Efficacy of Azithromycin Versus Ceftriaxone in Treatment of Enteric Fever
Description:
Objective: Research was conducted at the Hayatabad Medical Complex in Peshawar to evaluate the relative effectiveness of azithromycin and ceftriaxone in the treatment of enteric fever.
Methods: After the ethical approval from institute review board, this random controlled trial was conducted at Department of Pediatrics, Hayatabad Medical Complex, Peshawar, from 20 July, 2019 to 20 Jan, 2020.
Each patient was randomly assigned to a treatment group through toss method in Group A and Group B.
Patients in Group A received azithromycin (20 mg/kg/day; maximum, 1000 mg/day) and patients in Group B were administered with ceftriaxone (75 mg/kg/day; maximum, 2.
5 g/day).
Efficacy of both drugs was determined keeping in view complete resolution of symptoms of enteric fever within a week time.
Results: The mean ± S.
D of age of the participants in both groups were 5.
38±1.
95 and 5.
74±1.
84 years.
The mean ± S.
D of disease duration of the participants in both groups were 6.
14±1.
25 and 5.
90±1.
17 days.
The mean ± S.
D of time of defersevence of the participants in both groups were 2.
38±0.
57 and 4.
66±0.
716.
In azithromycin group, 44 (88%) patients showed effective results while in the ceftriaxone group, 23 (46%) patients showed effective results.
P Value = 0.
000 Conclusion: Azithromycin could be a convenient and cheap alternative for the treatment of typhoid fever, especially in children in our local population.
Keywords: Azithromycin, Ceftriaxone, Typhoid Fever.
Related Results
Comparison of efficacy of intravenous ceftraixone versus oral azithromycin in uncomplicated enteric fever.
Comparison of efficacy of intravenous ceftraixone versus oral azithromycin in uncomplicated enteric fever.
Objective: To compare the efficacy of intravenous ceftriaxone vs oral azithromycin in uncomplicated enteric fever. Study Design: Prospective Cohort study. Setting: Department of Pe...
Comparison of Culture Proven Enteric Fever Treatment with Meropenem Alone Vs Combination of Meropenem and Azithromycin
Comparison of Culture Proven Enteric Fever Treatment with Meropenem Alone Vs Combination of Meropenem and Azithromycin
Background: Enteric fever, primarily caused by Salmonella enterica serotypes Typhi and Paratyphi, remains a significant global health challenge, particularly in regions with limite...
Barriers to accessibility of ceftriaxone among adult postoperative patients at Mulago National Referral Hospital, Uganda
Barriers to accessibility of ceftriaxone among adult postoperative patients at Mulago National Referral Hospital, Uganda
Abstract
Background: Access to ceftriaxone is still low, causing 11% of patients not to complete their treatment at health facilities in Uganda; which could increase antimi...
Lower gastrointestinal bleeding as a complication of enteric fever: A case report
Lower gastrointestinal bleeding as a complication of enteric fever: A case report
Enteric fever is a systemic bacterial infection caused by enteroinvasive, gram-negative bacilli, named Salmonella enterica serovar typhi and Salmonella enterica serovar paratyphi. ...
CLINICAL EFFICACY OF ORAL AZITHROMYCIN VERSUS OTHER ANTIMICROBIAL DRUGS IN THE TREATMENT OF TYPHOID PATIENTS ACROSS ALL AGE GROUPS: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS
CLINICAL EFFICACY OF ORAL AZITHROMYCIN VERSUS OTHER ANTIMICROBIAL DRUGS IN THE TREATMENT OF TYPHOID PATIENTS ACROSS ALL AGE GROUPS: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS
Background: Typhoid is a major health concern. Drug-resistant cases of typhoid have given rise to new debates. Azithromycin has shown adequate results. The study is designed to det...
Analisa Pemberian Azitromicin Sebagai Obat COVID-19 pada Pasien Terkonformasi Positif di Indonesia
Analisa Pemberian Azitromicin Sebagai Obat COVID-19 pada Pasien Terkonformasi Positif di Indonesia
Antibiotics are given to corona patients if the doctor feels it is necessary because the patient is infected by certain bacteria. For example, a coronavirus patient is exposed to b...
Enteric glia
Enteric glia
AbstractThe structure of the enteric nervous system (ENS) is different from that of extraenteric peripheral nerve. Collagen is excluded from the enteric plexuses and support for ne...
Role of Azithromycin in Enteric Fever
Role of Azithromycin in Enteric Fever
Background: In low- and middle-income nations, particularly in South Asia, where growing resistance to first-line and fluoroquinolone antibiotics has made treatment more difficult,...

